No profile data available.
Black Diamond Therapeutics, Inc. (BDTX) is a healthcare company in the additional cancer treatment drugs industry, based in Cambridge, United States, with about 21 full-time employees.
In Q3 2025 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $105.14 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
$105.14 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include enGene Holdings Inc. (ENGN), Genelux Corporation (GNLX), PMV Pharmaceuticals, Inc. (PMVP), Corbus Pharmaceuticals Holdings, Inc. (CRBP).